1. Home
  2. TEVA vs CINF Comparison

TEVA vs CINF Comparison

Compare TEVA & CINF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • CINF
  • Stock Information
  • Founded
  • TEVA 1901
  • CINF 1950
  • Country
  • TEVA Israel
  • CINF United States
  • Employees
  • TEVA N/A
  • CINF N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • CINF Property-Casualty Insurers
  • Sector
  • TEVA Health Care
  • CINF Finance
  • Exchange
  • TEVA Nasdaq
  • CINF Nasdaq
  • Market Cap
  • TEVA 19.7B
  • CINF 19.8B
  • IPO Year
  • TEVA N/A
  • CINF N/A
  • Fundamental
  • Price
  • TEVA $18.38
  • CINF $138.38
  • Analyst Decision
  • TEVA Strong Buy
  • CINF Buy
  • Analyst Count
  • TEVA 8
  • CINF 8
  • Target Price
  • TEVA $19.25
  • CINF $134.29
  • AVG Volume (30 Days)
  • TEVA 4.9M
  • CINF 466.8K
  • Earning Date
  • TEVA 11-06-2024
  • CINF 10-24-2024
  • Dividend Yield
  • TEVA N/A
  • CINF 2.34%
  • EPS Growth
  • TEVA N/A
  • CINF 58.67
  • EPS
  • TEVA N/A
  • CINF 13.63
  • Revenue
  • TEVA $16,290,000,000.00
  • CINF $10,646,000,000.00
  • Revenue This Year
  • TEVA $4.59
  • CINF N/A
  • Revenue Next Year
  • TEVA $4.06
  • CINF $2.43
  • P/E Ratio
  • TEVA N/A
  • CINF $10.17
  • Revenue Growth
  • TEVA 8.48
  • CINF 13.61
  • 52 Week Low
  • TEVA $8.07
  • CINF $96.86
  • 52 Week High
  • TEVA $19.08
  • CINF $142.25
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 59.65
  • CINF 57.79
  • Support Level
  • TEVA $17.73
  • CINF $136.58
  • Resistance Level
  • TEVA $18.33
  • CINF $142.25
  • Average True Range (ATR)
  • TEVA 0.38
  • CINF 2.34
  • MACD
  • TEVA 0.10
  • CINF 0.35
  • Stochastic Oscillator
  • TEVA 93.00
  • CINF 69.76

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About CINF Cincinnati Financial Corporation

Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The company operates in segments: Commercial lines insurance, Personal lines insurance, and Excess and surplus lines insurance, Life insurance, and Investments. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.

Share on Social Networks: